InvestorsHub Logo
Followers 21
Posts 3704
Boards Moderated 0
Alias Born 09/25/2012

Re: Protector post# 263759

Wednesday, 05/11/2016 10:40:45 AM

Wednesday, May 11, 2016 10:40:45 AM

Post# of 346071

As explained before I see SUNRISE stopping as a DELAY to market for Bavituximab not as a change of value.

what about the cost of the trial, the time to market, the added competition in the market, the operating costs of pphm for the time of the trial, the operating costs for pphm from now till next trial result .... there are no costs or value destruction components at all in pphm-land?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News